Skip to content
PICO Portalanswers from OpenAlex

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD

PaperCitations, authors & open-access status

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD is a paper indexed in PICO Portal from OpenAlex.

How many citations does Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD have?

PICO Portalcitation count

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD has 212 citations in the OpenAlex counts PICO Portal stores.

When was Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD published?

PICO Portalyear

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD has 2004 year in the PICO Portal index.

What is the open-access status of Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD?

PICO Portaloa status

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD has closed oa status in the PICO Portal index.

What is the DOI of Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD?

PICO Portaldoi

The DOI for Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD is on the source record.

What is the PMID of Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD?

PICO Portalpmid

The PMID for Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD is on the source record.

What is the OpenAlex record for Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD?

PICO Portalopenalex

The OpenAlex for Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial